These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1299 related items for PubMed ID: 12660669

  • 1. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S.
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [Abstract] [Full Text] [Related]

  • 2. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
    Paterna S, Di Pasquale P, Parrinello G, Amato P, Cardinale A, Follone G, Giubilato A, Licata G.
    Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
    [Abstract] [Full Text] [Related]

  • 3. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
    Paterna S, Di Pasquale P, Parrinello G, Fornaciari E, Di Gaudio F, Fasullo S, Giammanco M, Sarullo FM, Licata G.
    J Am Coll Cardiol; 2005 Jun 21; 45(12):1997-2003. PubMed ID: 15963399
    [Abstract] [Full Text] [Related]

  • 4. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S, Parrinello G, Cannizzaro S, Fasullo S, Torres D, Sarullo FM, Di Pasquale P.
    Am J Cardiol; 2009 Jan 01; 103(1):93-102. PubMed ID: 19101237
    [Abstract] [Full Text] [Related]

  • 5. Tolerability and efficacy of high-dose furosemide and small-volume hypertonic saline solution in refractory congestive heart failure.
    Paterna S, Parrinello G, Amato P, Dominguez L, Pinto A, Maniscalchi T, Cardinale A, Licata A, Amato V, Licata G, Di Pasquale P.
    Adv Ther; 1999 Jan 01; 16(5):219-28. PubMed ID: 10915397
    [Abstract] [Full Text] [Related]

  • 6. Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study).
    Paterna S, Fasullo S, Parrinello G, Cannizzaro S, Basile I, Vitrano G, Terrazzino G, Maringhini G, Ganci F, Scalzo S, Sarullo FM, Cice G, Di Pasquale P.
    Am J Med Sci; 2011 Jul 01; 342(1):27-37. PubMed ID: 21701268
    [Abstract] [Full Text] [Related]

  • 7. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.
    Pediatrics; 2006 Jul 01; 118(1):e76-84. PubMed ID: 16751617
    [Abstract] [Full Text] [Related]

  • 8. High-Dose Torasemide is Equivalent to High-Dose Furosemide with Hypertonic Saline in the Treatment of Refractory Congestive Heart Failure.
    Paterna S, Fasullo S, Di Pasquale P.
    Clin Drug Investig; 2005 Jul 01; 25(3):165-73. PubMed ID: 17523765
    [Abstract] [Full Text] [Related]

  • 9. Changes in estimating echocardiography pulmonary capillary wedge pressure after hypersaline plus furosemide versus furosemide alone in decompensated heart failure.
    Parrinello G, Paterna S, Di Pasquale P, Torres D, Mezzero M, Cardillo M, Fasullo S, La Rocca G, Licata G.
    J Card Fail; 2011 Apr 01; 17(4):331-9. PubMed ID: 21440872
    [Abstract] [Full Text] [Related]

  • 10. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G, Weissgarten J, Metzkor E, Moshkovitz Y, Litinski I, Tavori U, Perry C, Zaidenstein R, Golik A.
    Clin Pharmacol Ther; 1997 Aug 01; 62(2):187-93. PubMed ID: 9284855
    [Abstract] [Full Text] [Related]

  • 11. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R, Ciccarelli A, Ariano C, Cioppa C, Giasi A, Pucciarelli A, Cantatrione S.
    Minerva Cardioangiol; 2011 Dec 01; 59(6):543-54. PubMed ID: 21330961
    [Abstract] [Full Text] [Related]

  • 12. Troponin I release after intravenous treatment with high furosemide doses plus hypertonic saline solution in decompensated heart failure trial (Tra-HSS-Fur).
    Parrinello G, Di Pasquale P, Torres D, Cardillo M, Schimmenti C, Lupo U, Iatrino R, Petrantoni R, Montaina C, Giambanco S, Paterna S.
    Am Heart J; 2012 Sep 01; 164(3):351-7. PubMed ID: 22980301
    [Abstract] [Full Text] [Related]

  • 13. Impact of Compound Hypertonic Saline Solution on Decompensated Heart Failure.
    Wan Y, Li L, Niu H, Ma X, Yang J, Yuan C, Mu G, Zhang J.
    Int Heart J; 2017 Aug 03; 58(4):601-607. PubMed ID: 28701670
    [Abstract] [Full Text] [Related]

  • 14. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V, Seferovic P, Dodic S, Krotin M, Neskovic A, Dickstein K, de Voogd H, Böcker C, Ziegler D, Godes M, Nakov R, Essers H, Verboom C, Hocher B.
    Circ Heart Fail; 2009 Nov 03; 2(6):523-31. PubMed ID: 19919976
    [Abstract] [Full Text] [Related]

  • 15. Clinical Trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites.
    Licata G, Tuttolomondo A, Licata A, Parrinello G, Di Raimondo D, Di Sciacca R, Cammà C, Craxì A, Paterna S, Pinto A.
    Aliment Pharmacol Ther; 2009 Aug 03; 30(3):227-35. PubMed ID: 19438847
    [Abstract] [Full Text] [Related]

  • 16. Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure.
    Paterna S, Di Gaudio F, La Rocca V, Balistreri F, Greco M, Torres D, Lupo U, Rizzo G, di Pasquale P, Indelicato S, Cuttitta F, Butler J, Parrinello G.
    Adv Ther; 2015 Oct 03; 32(10):971-82. PubMed ID: 26521190
    [Abstract] [Full Text] [Related]

  • 17. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure.
    Pivac N, Rumboldt Z, Sardelić S, Bagatin J, Polić S, Ljutić D, Naranca M, Capkun V.
    Int J Clin Pharmacol Res; 1998 Oct 03; 18(3):121-8. PubMed ID: 9825268
    [Abstract] [Full Text] [Related]

  • 18. High-dose furosemide and small-volume hypertonic saline solution infusion for the treatment of leg edema in advanced cancer patients.
    Mercadante S, Villari P, Ferrera P, David F, Intravaia G.
    J Pain Symptom Manage; 2009 Mar 03; 37(3):419-23. PubMed ID: 18790601
    [Abstract] [Full Text] [Related]

  • 19. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A, Silverberg D, Iovine F, Capobianco S, Giannotti G, Calabrò A, Campagna SM, Nuti R.
    Am Heart J; 2006 Dec 03; 152(6):1096.e9-15. PubMed ID: 17161060
    [Abstract] [Full Text] [Related]

  • 20. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S, Warfield KT, Wood CM, Miller WL.
    Am J Cardiol; 2006 Dec 15; 98(12):1627-30. PubMed ID: 17145223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.